Received Aug 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
want to have the second shot this year.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose back in 2018 with batch number NX952 and lot expiry 06-MAR-2020). On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: want to have the second shot this year.). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 11-AUG-2025 The pharmacist called to get guidance on the Shingrix vaccination series the patient got the first shot back in 2018 and want to have the second shot this year. The health care professional wanted to know if the complete series have to be restarted. The vaccine administration facility was the same as primary reporter. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. This case is linked with US2025103484, reported by same reporter.